Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 30;15(9):1843.
doi: 10.3390/v15091843.

Antibiotic-Resistant ESKAPE Pathogens and COVID-19: The Pandemic beyond the Pandemic

Alessia Catalano  1 , Domenico Iacopetta  2 , Jessica Ceramella  2 , Michele Pellegrino  2 , Federica Giuzio  3 , Maria Marra  2 , Camillo Rosano  4 , Carmela Saturnino  3 , Maria Stefania Sinicropi  2 , Stefano Aquaro  2
Affiliations
Review

Antibiotic-Resistant ESKAPE Pathogens and COVID-19: The Pandemic beyond the Pandemic

Alessia Catalano et al. Viruses. .

Abstract

Antibacterial resistance is a renewed public health plague in modern times, and the COVID-19 pandemic has rekindled this problem. Changes in antibiotic prescribing behavior, misinformation, financial hardship, environmental impact, and governance gaps have generally enhanced the misuse and improper access to antibiotics during the COVID-19 pandemic. These determinants, intersected with antibacterial resistance in the current pandemic, may amplify the potential for a future antibacterial resistance pandemic. The occurrence of infections with multidrug-resistant (MDR), extensively drug-resistant (XDR), difficult-to-treat drug-resistant (DTR), carbapenem-resistant (CR), and pan-drug-resistant (PDR) bacteria is still increasing. The aim of this review is to highlight the state of the art of antibacterial resistance worldwide, focusing on the most important pathogens, namely Enterobacterales, Acinetobacter baumannii, and Klebsiella pneumoniae, and their resistance to the most common antibiotics.

Keywords: COVID-19; DTR; ESKAPE; MDR; PDR; SARS-CoV-2; XDR; antibacterial resistance; antibacterials; post-COVID.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Strathdee S.A., Davies S.C., Marcelin J.R. Confronting antimicrobial resistance beyond the COVID-19 pandemic and the 2020 US election. Lancet. 2020;396:1050–1053. doi: 10.1016/S0140-6736(20)32063-8. - DOI - PMC - PubMed
    1. World Health Organization Global Action Plan on Antimicrobial Resistance. [(accessed on 20 June 2023)];2015 Available online: https://apps.who.int/iris/handle/10665/193736.
    1. World Health Organization . One Health Joint Plan of Action (2022–2026): Working Together for the Health of Humans, Animals, Plants and the Environment. WHO; Geneva, Switzerland: 2022.
    1. Jesudason T. A new One Health Joint Action Plan. Lancet Infect. Dis. 2022;22:1673. doi: 10.1016/S1473-3099(22)00751-4. - DOI - PubMed
    1. Calvo-Villamañán A., San Millán Á., Carrilero L. Tackling AMR from a multidisciplinary perspective: A primer from education and psychology. Int. Microbiol. 2022;26:1–9. doi: 10.1007/s10123-022-00278-1. - DOI - PMC - PubMed

Publication types